Intravenous Immunoglobulin (IVIg) Market Analysis and Key Insights The Intravenous Immunoglobulin (IVIg) Market is witnessing robust growth due to rising incidences of immune deficiencies and autoimmune diseases. According to MRFR, the market is expanding as healthcare providers increasingly adopt IVIg therapies for chronic and rare conditions. Technological advancements in IVIg production and...

The global intravenous immunoglobulin market was valued at USD 14.9 billion in 2025 and is expected to reach USD 16.0 billion in 2026, rising to USD 25.7 billion by 2033. The market is projected to expand at a 7.0% CAGR from 2026 to 2033. North America accounted for the largest revenue share at 45.9% in 2025, while Asia Pacific is anticipated to register the fastest growth during the forecast...

The U.S. intravenous immunoglobulin (IVIG) market was valued at USD 5.74 billion in 2022 and is projected to expand at a 7.7% CAGR from 2023 to 2030. Growth is being supported by increasing demand for immunoglobulin replacement therapy among patients with Primary Immunodeficiency Diseases (PIDD), along with the approval of new IVIG products that are broadening available treatment options. What...

Intravenous Immunoglobulin (IVIg) Market Demand and Global Outlook The Intravenous Immunoglobulin (IVIg) Market is experiencing strong demand due to rising prevalence of immune-related disorders and increased adoption of IVIg therapy in hospitals and clinics worldwide. MRFR reports that growing awareness among healthcare professionals and patients is accelerating adoption, while manufacturers...